Equities

Avacta Group PLC

AVCT:LSE

Avacta Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)51.50
  • Today's Change2.00 / 4.04%
  • Shares traded1.97m
  • 1 Year change-57.96%
  • Beta1.8162
Data delayed at least 20 minutes, as of Sep 27 2024 17:07 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Avacta Group PLC grew revenues 140.83% from 9.65m to 23.25m while net income improved from a loss of 36.63m to a smaller loss of 24.95m.
Gross margin48.37%
Net profit margin-107.31%
Operating margin-121.99%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Avacta Group PLC fell by 25.15m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 14.87m for operations while cash used for investing totalled 9.00m.
Cash flow per share-0.078
Price/Cash flow per share--
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in GBPView more

Avacta Group PLC uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.